medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2011, Number 1

<< Back Next >>

Ann Hepatol 2011; 10 (1)

Protective effect of four Mexican plants against CCl4-induced damage on the Huh7 human hepatoma cell line

Torres-González L, Muñoz-Espinosa LE, Rivas-Estilla AM, Trujillo-Murillo K, Salazar-Aranda R, Waksman TNCordero-Pérez P

Language: English
References: 45
Page: 73-79
PDF size: 75.58 Kb.


ABSTRACT

Background. Centaurea americana, Krameria ramosissima, Juglans mollis and Turnera diffusa are used by traditional healers in the northeastern region of Mexico to protect against liver damage. However, the hepatoprotective properties of these plants have not been investigated scientifically. This study reports on the protective effects of these plants using an in vitro assay. Material and methods. Extracts of plants were tested for antioxidant activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging method. The effects of extracts from these plants on a human hepatoma cell line (Huh7) were evaluated according to cell viability and aspartate aminotransferase and malondialdehyde levels before and after exposure of the cells to carbon tetrachloride (CCl4). Results. All extracts reduced DPPH levels by more than 50%. C. americana flower and stem/leaf extracts, the aerial part of T. diffusa, and the nut, leaf and bark of J. mollis extracts were used to assess hepatoprotective activity. The extract of the aerial part of K. ramosissima was toxic. Pretreatment of Huh7 cells with extracts from the flower of C. americana (FCA), the stem/leaf fraction of C. americana (S/LCA), the leaf of J. mollis (LJM) and the bark of J. mollis (BJM) prior to the CCl4 challenge, protected against CCl4-induced liver damage, as evidenced by a significant decrease in the activity of the medium enzyme. The FCA, S/LCA, LJM and BJM extracts showed significant antilipid peroxidant effects in vitro. In conclusion, the hepatoprotective effects of the FCA, S/LCA, LJM and BJM extracts observed in this study may result from their antioxidative properties.


REFERENCES

  1. Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-6.

  2. Méndez-Sánchez N, Villa AR, Chavéz-Tapia NC, Ponciano- Rodriguez G, Almeda-Valdés P, González D, Uribe M. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005; 4: 52-5.

  3. Foster BC, Arnason JT, Briggs CJ. Natural health products and drug disposition. Annu Rev Pharmacol Toxicol 2005; 45: 203-26.

  4. Matteuci E, Giampietro O. Proposal open for discussion: defining agreed diagnostic procedures in experimental diabetes research. J Ethnopharmacol 2008; 115: 163-72.

  5. Hamilton AC. Medicinal plants, conservation and livelihoods. Biodiversity and Conservation 2004; 13: 1477-517.

  6. Lee KH. Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. J Nat Prod 2010; 73: 500-16.

  7. Johnson JJ, Bailey HH, Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010; 17: 3-13.

  8. Tolstikova TG, Khvostov MV, Bryzgalov AO. The complexes of drugs with carbohydrate-containing plant metabolites as pharmacologically promising agents. Mini Rev Med Chem 2009; 9: 1317-28.

  9. Oliver-Bever B. Drugs plants in ancient and modern Mexico. Annu Rev Pharmacol Toxicol 1972; 12: 1957-72.

  10. De Micheli A, Izaguirre-Avila R. On Mexican medicinal plants. Arch Cardiol Mex 2009; 79: 95-101.

  11. García-Alvarado SJ, Verde-Star MJ, Herendia NL. Traditional uses and scientific knowledge of medicinal plants from Mexico and Central America. J Herbs Spices Med Plants 2001; 8: 37-89.

  12. Salazar R, Pozos ME, Cordero P, Perez J, Salinas MC, Waskman N. Determination of the antioxidant activity of six plants from Northeast Mexico. Pharm Biol 2008; 46: 166-70.

  13. Lee SE, Hwang HJ, Ha JS, Jeong HS, Kim JH. Screening of medicinal plant extracts for antioxidant activity. Life Sci 2003; 73: 167-79.

  14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.

  15. Gómez-Lechón MJ, Lahoz A, Gombau L, Castell JV, Donato MT. In vitro evaluation of potential hepatotoxicity induced by drugs. Curr Pharm Des 2010; 16: 1963-77.

  16. Kikkawa R, Yamamoto T, Fukushima T, Yamada H, Horii I. Investigation of a hepatotoxicity screening system in primary cell cultures - “What biomarkers would need to be addressed to estimate toxicity in conventional and new approaches?” J Toxicol Sci 2005; 30: 61-72.

  17. Groneberg DA, Grosee-Siestrup C, Fischer A. In vitro models to study hepatotoxicity. Toxicol Pathol 2002; 30: 394-9.

  18. Dambach DM, Andrews BA, Moulin F. New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol 2005; 33: 17-26.

  19. Luper S. A review of plants used in the treatment of liver disease: Part 1. Altern Med Rev 1998; 3: 410-21.

  20. Luper S. A review of plants used in the treatment of liver disease: Part Two. Altern Med Rev 1999; 4: 178-88.

  21. Hamburger M, Hostettmann K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 1991; 30: 3864-74.

  22. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999; 30: 1099-104.

  23. Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Complementary and alternative medicine in chronic liver disease. Hepatology 2001; 34: 595-603.

  24. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000; 63: 1035-42.

  25. Fogden E, Neuberger J. Alternative medicine and the liver. Liver Int 2003; 23: 213-20.

  26. Ball KR, Kowdley K. A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease. J Clin Gastroenterol 2005; 39: 520-8.

  27. Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat 2005; 12: 559-67.

  28. Koleva II, Van Beek T, Linssen J P, De Groot A, Evstatieva LN. Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochem Anal 2001; 13: 8-17.

  29. Kiso Y, Tohkin M, Hikino H. Assay method for antihepatotoxic activity using carbon tetrachloride induced cytotoxicity in primary cultured hepatocytes. Planta Med 1983; 49: 222-5.

  30. Slater TF, Cheeseman KH, Ingold KU. Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury. Phil Trans R Soc Lond B Bio Sci 1985; 311: 633-45.

  31. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003; 33: 105-36.

  32. Dandagi PM, Patil MB, Mastiholimath VS, Gadad AP, Dhumansure RH. Development and evaluation of hepatoprotective polyherbal formulation containing some indigenous medicinal plants. Indian J Pharm Sci 2008; 70: 265-8.

  33. Shyamal S, Latha PG, Shine VJ, Suja SR, Rajasekharan S, Ganga Devi T. Hepatoprotective effects of Pittosporum neelgherrense Wight&Arn., a popular Indian ethnomedicine. J Ethnopharmacol 2006; 107: 151-5.

  34. Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver disease: past, present, future. Phytother Res 2010. In press.

  35. Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat 2005; 12: 559-67.

  36. USDA-ARS-GRIN Database, 2006. USDA, ARS, National Genetic Resources Program, Germplasm Resources Information Network (GRIN). National Germplasm Resources Laboratory, Beltsville, MD, USA. Available from: .

  37. Heinrich M, Robles M, West JE, Ortiz de Montellano BR, Rodriguez E. Ethnopharmacology of Mexican Asteraceae (Compositae). Annu Rev Pharmacol Toxicol 1998; 38: 539-65.

  38. Shoeb M, MacManus SM, Kumarasamy Y, Jaspars M, Nahar L, Thoo-Lin PK, Nazemiyeh H, et al. Americanin, a bioactive dibenzylbutyrolactone lignan, from the seeds of Centaurea americana. Phytochemistry 2006; 67: 2370-5.

  39. Ren-Bo A, Hyun-Chul K, Yu-Hua T, Youn-Chul K. Free radical scavenging and hepatoprotective constituents from the leaves of Juglans sinensis. Arch Pharm Res 2005; 28; 529-33.

  40. Fukuda T, Ito H, Yoshida T. Antioxidative polyphenols from walnuts (Juglans regia L.). Phytochemistry 2003; 63: 795-801.

  41. Carvalho M, Ferreira PJ, Mendes VS, Silva R, Pereira JA, Jerónimo C, Silva BM. Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food Chem Toxicol 2010; 48: 441-7.

  42. Asgary S, Parkhideh S, Solhpour A, Madani H, Mahzouni P, Rahimi P. Effect of ethanolic extract of Juglans regia L. on blood sugar in diabetes-induced rats. J Med Food 2008; 11: 533-8.

  43. Aradhya MK, Potter D, Gao F, Simon CJ. Molecular phylogeny of Juglans (Juglandaceae): a biogeographic perspective. Tree Genet. Genomes 2007; 3: 363-78.

  44. Fernandez R, Ramos D. Notas sobre plantas medicinales del estado de Querétaro, México. Polibotánica 2001; 12: 1-40.

  45. Cruz-Vega DE, Verde-Star MJ, Salinas-González N, Rosales- Hernández B, Estrada-García I, Mendez-Aragón P, Carranza- Rosales P, et al. Antimycobacterial activity of Juglans regia, Juglans mollis, Carya illinoensis and Bocconia frutescens. Phytother Res 2008; 22: 557-9.




2020     |     www.medigraphic.com